RecruitingPhase 4NCT07816835

Nebulizer Versus Handheld Maintenance Therapy for Patients With COPD


Sponsor

COPD Foundation

Enrollment

120 participants

Start Date

Jul 14, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

Multi-site, randomized controlled trial to determine whether patients who report NO symptomatic benefit with their maintenance hand-held inhaler(s), benefit upon switching to nebulized therapy using comparable classes of medications.


Eligibility

Min Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Continue handheld therapy and a medical device called Nebulized therapy of similar medication solutions for people with copd, chronic obstructive pulmonary disease and chronic obstructive pulmonary disease (copd). The study is currently recruiting participants at 2 locations. People eligible for this study include aged 60 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICENebulized therapy of similar medication solutions

LABA/LAMA or LABA/LAMA/ICS nebulized solutions

DEVICEContinue handheld therapy

Continue with current handheld LABA/LAMA or LABA/LAMA/ICS therapy


Locations(2)

Midwest Chest Consultants, P.C.

Saint Charles, Missouri, United States

Southeastern Research Center

Winston-Salem, North Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07816835


Related Trials